Related references
Note: Only part of the references are listed.Tumor-associated status epilepticus in patients with glioma: Clinical characteristics and outcomes
Giada Giovannini et al.
EPILEPSY & BEHAVIOR (2019)
Seizures in glioma patients: An overview of incidence, etiology, and therapies
Niyatee Samudra et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Varun Venkataramani et al.
NATURE (2019)
Antiepileptic drugs as prophylaxis for de novo brain tumour-related epilepsy after craniotomy: a systematic review and meta-analysis of harm and benefits
Christian Mirian et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Glutamate weighted imaging contrast in gliomas with 7 Tesla magnetic resonance imaging
Andrew Neal et al.
NEUROIMAGE-CLINICAL (2019)
Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology
Robert S. Fisher et al.
EPILEPSIA (2017)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Metabolomic signature of brain cancer
Renu Pandey et al.
MOLECULAR CARCINOGENESIS (2017)
Peritumoural glutamate correlates with post-operative seizures in supratentorial gliomas
Andrew Neal et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Seizures and gliomas - towards a single therapeutic approach
Gilles Huberfeld et al.
NATURE REVIEWS NEUROLOGY (2016)
Epilepsy in Adults with Supratentorial Glioblastoma: Incidence and Influence Factors and Prophylaxis in 184 Patients
Shuli Liang et al.
PLOS ONE (2016)
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
Jan Lewerenz et al.
FRONTIERS IN NEUROSCIENCE (2015)
Efficacy of postoperative seizure prophylaxis in intra-axial brain tumor resections
Shaheryar F. Ansari et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Quantification in magnetic resonance spectroscopy based on semi-parametric approaches
Danielle Graveron-Demilly
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2014)
Clinical Proton MR Spectroscopy in Central Nervous System Disorders
Gulin OZ et al.
RADIOLOGY (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Potential of MR spectroscopy for assessment of glioma grading
Martin Bulik et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
Seizure characteristics and prognostic factors of gliomas
Melissa Kerkhof et al.
EPILEPSIA (2013)
Glutamate is associated with a higher risk of seizures in patients with gliomas
Tanya I. Yuen et al.
NEUROLOGY (2012)
Brainstem Metabolites in Multiple System Atrophy of Cerebellar Type: 3.0-T Magnetic Resonance Spectroscopy Study
Yuhei Takado et al.
MOVEMENT DISORDERS (2011)
Revisiting AMPA Receptors as an Antiepileptic Drug Target
Michael A. Rogawski
EPILEPSY CURRENTS (2011)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Stephen F. Traynelis et al.
PHARMACOLOGICAL REVIEWS (2010)
Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications
D. P. Soares et al.
CLINICAL RADIOLOGY (2009)
Glutamate-induced glioma cell proliferation is prevented by functional expression of the glutamate transporter GLT-1
Nicolas Vanhoutte et al.
FEBS LETTERS (2008)
Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation
Shogo Ishiuchi et al.
JOURNAL OF NEUROSCIENCE (2007)
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management
Melanie S. M. van Breemen et al.
LANCET NEUROLOGY (2007)
Increased thalamus levels of glutamate and glutamine (Glx) in patients with idiopathic generalised epilepsy
G Helms et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures
JC Jen et al.
NEUROLOGY (2005)
The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo
JF de Groot et al.
CANCER RESEARCH (2005)
Myoinositol abnormalities in temporal lobe epilepsy
RM Wellard et al.
EPILEPSIA (2003)
Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI
D Yang et al.
NEURORADIOLOGY (2002)
Automatic quantitation of localized in vivo 1H spectra with LCModel
SW Provencher
NMR IN BIOMEDICINE (2001)